HOUSTON, Sept. 3, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announces the company's management team will participate in two upcoming investor conferences this month.H.C. Wainwright 27th Annual Global Investment ConferenceDate: September 10, 2025Time: 10 am ETFormat: Presentation by Arun Swaminathan, Ph ...